COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 105 filers reported holding COHERUS BIOSCIENCES INC in Q1 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $223,000 | -4.7% | 23,204 | -28.3% | 0.01% | -20.0% |
| Q2 2022 | $234,000 | -54.3% | 32,347 | -18.5% | 0.01% | -58.3% |
| Q1 2022 | $512,000 | +84.2% | 39,676 | +128.0% | 0.02% | +41.2% |
| Q4 2021 | $278,000 | -42.2% | 17,404 | -47.2% | 0.02% | -61.4% |
| Q1 2021 | $481,000 | +40.6% | 32,947 | +72.0% | 0.04% | +83.3% |
| Q2 2020 | $342,000 | -38.6% | 19,152 | -24.0% | 0.02% | -52.0% |
| Q2 2019 | $557,000 | +92.1% | 25,213 | +18.7% | 0.05% | +138.1% |
| Q1 2019 | $290,000 | -75.3% | 21,236 | -70.2% | 0.02% | -76.1% |
| Q3 2018 | $1,176,000 | +583.7% | 71,266 | +481.8% | 0.09% | +633.3% |
| Q2 2018 | $172,000 | -55.9% | 12,250 | -65.3% | 0.01% | -55.6% |
| Q1 2018 | $390,000 | +22.3% | 35,252 | +134.1% | 0.03% | -34.1% |
| Q1 2017 | $319,000 | -44.4% | 15,061 | -29.7% | 0.04% | -68.0% |
| Q3 2016 | $574,000 | +69.8% | 21,421 | +6.9% | 0.13% | +190.9% |
| Q2 2016 | $338,000 | -56.0% | 20,039 | -47.8% | 0.04% | -33.3% |
| Q3 2015 | $769,000 | – | 38,400 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |